Lipids and brain inflammation in APOE4-associated dementia

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• The apolipoprotein E4 (APOE4) allele is a significant genetic risk factor for Alzheimer's disease (AD).
• Understanding the molecular mechanisms linking APOE4 to AD pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

• To review recent advancements in understanding how the APOE4 allele influences brain lipid metabolism.
• To elucidate the role of APOE4 in promoting brain inflammation and AD dementia.

Main Methods:

• Review of current research on APOE4's effects on brain lipid metabolism.
• Analysis of signaling pathways involving phospholipase A2 (PLA2) and fatty acids.
• Discussion of brain imaging techniques for assessing fatty acid uptake.

Main Results:

• APOE4 activates Ca2+-dependent phospholipase A2 (cPLA2), altering brain fatty acid metabolism.
• Increased conversion of arachidonic acid (AA) to eicosanoids contributes to chronic brain inflammation.
• APOE4's effects are modulated by age, disease stage, and nutritional status, detectable via brain imaging.

Conclusions:

• Modulating cPLA2 activity presents a potential therapeutic avenue for APOE4-associated dementia.
• Brain fatty acid imaging can provide insights into AD progression and guide anti-inflammatory drug development.